Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

CSTL Q4 2018 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

Q4 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$11M

Gross Profit

$10M88.1% margin

Operating Income

$5M41.7% margin

Net Income

$4M33.8% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+208.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$72,907

Balance Sheet

Total Assets

$22M

Total Liabilities

$32M

Stockholders' Equity

-$10M

Cash & Equivalents

$4M

← FY 2018 All Quarters Q1 2019 →